Health

Medicines are going vegan, too

Medication in powder, tablet or capsule form often contains magnesium stearate, which can be of animal origin

Updated 4 years ago · Published on 17 Mar 2022 10:15AM

Medicines are going vegan, too
Magnesium stearate is generally of animal origin, but Paraveganio uses a vegetable-based alternative. – ETX Daily Up pic, March 17, 2022

DID you know that the vast majority of medicines available in pharmacies contain, among other things, products of animal origin? Medication in powder, tablet or capsule form often contains magnesium stearate – the magnesium salt of the fatty acid, stearic acid – which can be of animal origin. However, some vegan-certified drugs, such as paracetamol, are beginning to arrive on the market.

Is the pharmaceutical industry ready to embrace veganism? For people who shun all animal products, accepting certain treatments can become a difficult choice. In fact, 75% of the most commonly prescribed drugs in the UK contain animal-derived products, warns the Vegan Society, a British association that campaigns in support of vegan lifestyles.

The composition of medicines can include products like gelatin, obtained from bones, and magnesium stearate. Magnesium stearate is generally obtained from animal fat. Some treatments also contain lactose, obtained from animal milk.

These components are not necessarily specified to the public.

"Of the 100 best-selling drugs, it is impossible to know whether or not the drug contains animal substances in 70% of cases," explains the Veggiepharm website, a French start-up that offers vegan medicines and food supplements. There is also the issue of animal testing, which goes against the beliefs of vegans.

The Vegan Society launched a campaign in 2017 called "Make More Medicines Vegan," aimed at the British government. Its goal was to raise awareness of plant-based solutions in the production of medicines.

Vegan medicines already on the market

But solutions seem to be coming from some pharmaceutical companies. At the beginning of March 2022, the German pharmaceutical firm Axunio launched a paracetamol of entirely vegetable origin, and without animal testing. This drug is the first to receive the Vegan Trademark certification from the Vegan Society.

Marketed as Paraveganio, this analgesic is as effective as the paracetamol that we are used to taking, explain the drug's creators. As such, it is recommended for use in cases of mild pain or fever.

It contains 500mg of paracetamol, but Paraveganio is animal-free, since it incorporates a vegetable alternative to magnesium stearate.

Similarly, the French laboratory Veggiepharm, founded in 2017, offers a paracetamol "with no extract of animal origin" made without testing on animals and certified by the Eve Vegan label. – ETX Daily Up, March 17, 2022

Related News

Malaysia / 2mth

Health Ministry sets up task force to address medicine supply crisis

Malaysia / 3mth

Malaysia to mandate early reporting of medicine shortage from July 2026 - Dzulkefly

Malaysia / 3mth

Domestic medicine supply remains stable and under control – MOH

Opinion / 5mth

A heart transplant journey

Malaysia / 6mth

Bachok IPD officer, personnel probed for allegedly blackmailing mother of drug suspect

Malaysia / 11mth

MOH, MCMC forge partnership to enhance national health system

Spotlight

Malaysia

Anwar congratulates BN on Johor victory, assures federal government support

Malaysia

Johor PRN: BN officially forms state government, wins 29 seats

Malaysia

Malaysia-Thailand open historic border crossing to deepen trade, regional integration

By Ian McIntyre

Malaysia

Gerak Khas drama actress, Tisha Samsir denies drug involvement

Malaysia

Student stabbing: Teenage girl sent to Hospital Bahagia for psychiatric evaluation

Malaysia

Anwar wishes Tun M a happy 101st birthday

World

Israel shares intelligence with US over alleged Iranian plot to assassinate Trump

You may be interested

Events

HashMicro rolls out AI-powered manufacturing platform to help firms tackle rising costs, disruptions

By Alfian Z.M. Tahir